Media Summary: PCRI's Executive Director, Mark Scholz, MD, talks about stereotactic body radiation therapy ( Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Michael J. Zelefsky, MD, explores outcomes for prostate brachytherapy vs. EBRT vs.
Sbrt For The Intermediate Risk - Detailed Analysis & Overview
PCRI's Executive Director, Mark Scholz, MD, talks about stereotactic body radiation therapy ( Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Michael J. Zelefsky, MD, explores outcomes for prostate brachytherapy vs. EBRT vs. Join Dr. Art Rastinehad in this enlightening session tailored for patients facing unfavorable PCRI's Executive Director, Mark Scholz, MD, explains a clinical trial (NCT03367702) for men with High-Sky and Low to Basic-Teal ... In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses radiation therapy for favorable
PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage ( MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for At the ESTRO 2025 Congress, Prof. Andrew Loblaw from the University of Toronto presented a comparative analysis of Dov Kadmon, MD, Professor of Urology at Baylor College of Medicine in Houston, Texas, provides a comprehensive overview of ... David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at ... Filmed in February 2020 Backed by extensive clinical evidence, the Decipher® Prostate Genomic Classifier helps clinicians and ...
This video will discuss the the success rate and the side effects with Cyberknife and surgery for unfavorable PCRI's Alex asks Dr. Scholz questions from our YouTube comments on the side effects of hormone therapy, whether it is ... There are many treatments for prostate cancer and one of them is radiation therapy. Within radiation therapy, there are all sorts of ... In this video, medical oncologist Dr. Mark Scholz compares two radiation therapy techniques: Intensity-Modulated Radiation ... PCRI's Executive Director, Mark Scholz, MD, talks about hormone therapy (TIP) as a standalone treatment for men with the Teal ... Christopher J. Kane, MD, FACS, the Dean of Clinical Affairs at the University of California San Diego School of Medicine, and the ...
Giulio Francolini, MD, University of Florence, Florence, Italy, provides an overview of the ULTRA-HERO trial design, a prospective ...